Skip to main content
Clinical Trials/ISRCTN95571932
ISRCTN95571932
Active, not recruiting
未知

A prospective study to assess the impact and benefits of an AI system in double reading for breast cancer screening

Kheiron Medical Technologies (United Kingdom)0 sites6,876 target enrollmentSeptember 29, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kheiron Medical Technologies (United Kingdom)
Enrollment
6876
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2023
End Date
August 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Kheiron Medical Technologies (United Kingdom)

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants routinely invited or self\-referred for breast screening
  • 2\. Participants identified as female
  • 3\. Participants for whom a 2D FFDM standard four\-view mammography examination was acquired

Exclusion Criteria

  • 1\. Patients with cosmetic breast implants
  • 2\. Very high risk patients, including genetic abnormalities etc.
  • 3\. Patients who have actively dissented from participation in the study
  • 4\. Cases marked as technical recall

Outcomes

Primary Outcomes

Not specified

Similar Trials